Latest updates: German biotech startup warns of ‘gaps’ in vaccine supply; re-analysis Covid tests in US raises questions about origin of B117 ‘UK strain’
- Key London hospital preparing for Covid-only care as cases surge
- New coronavirus variant may have been in US since October
- UK doctors despair over public’s disregard for rules
- See all our coronavirus coverage
India’s drug regulator is set to approve on Friday a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, three sources with knowledge of the matter said.
The decision would pave the way for the vaccine’s rollout in the world’s second-most populous country which, after the United States, has the highest number of Covid-19 infections in the world.
The UK and Argentina have already authorised the vaccine for urgent public use.
Australia welcomed 2021 with subdued celebrations as fresh coronavirus restrictions and border closures at its two most populous states forced families to ditch New Year plans.
Media reported traffic jams at border check-points stretching as long as 40 km (25 miles) as people rushed home to avoid border restrictions that kick in from midnight.